On Thursday, Shares of The Coca-Cola Co (NYSE:KO), lost -0.82% to $39.79.
The Coca-Cola Company agreed to change labels on its Vitaminwater beverages to resolve a lawsuit claiming it overstated their health benefits, but will not owe damages to consumers who alleged they were misled into buying the drinks, according to Reuters.
Under a settlement made public late Wednesday and ending more than six years of litigation, Coca-Cola would add the words “with sweeteners” in two places on Vitaminwater bottles, and display calorie counts more prominently.
It would also stop making some claims about the beverages, counting the phrase “vitamins + water = all you need” and that drinking Vitaminwater may improve metabolic or immune functions or reduce the risk of eye disease.
The settlement requires approval by a federal judge in Brooklyn, New York. Reuters Reports
The Coca-Cola Company is a beverage company. The Company owns or licenses and markets more than 500 nonalcoholic beverage brands, primarily sparkling beverages but also a range of still beverages, such as waters, improved waters, juices and juice drinks, ready-to-drink teas and coffees, and energy and sports drinks.
Shares of Ambev SA (ADR) (NYSE:ABEV), inclined 0.82% to $4.94, during its last trading session.
Ambev, declares recently its results for the 2015 second quarter. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the six-month period ended June 30, 2015 filed with the CVM and presented to the SEC.
Ambev SA, known as Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewers sector. Ambev produces, distributes and sell beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated products across the Americas.
Shares of Johnson & Johnson (NYSE:JNJ), declined -0.19% to $93.17, during its last trading session.
Johnson & Johnson, declared it has accomplished the divestiture of the SPLENDA® brand to Heartland Food Products Group. Global sales for the SPLENDA® brand were about $370 million in 2014. Financial terms of the transaction have not been revealed.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world.
Finally, salesforce.com, inc. (NYSE:CRM), ended its last trade with 5.00% gain, and closed at $72.90.
salesforce.com, stated that it granted equity awards under its 2014 Inducement Equity Incentive Plan to new employees who joined Salesforce in connection with its acquisition of Kerensen Consulting. The Plan was adopted by the Board of Directors in July 2014, in accordance with New York Stock Exchange Rule 303A.08.
Kerensen is a leading cloud consulting firm in Europe that provides business consulting, cloud solution administration and digital customer experience services. Salesforce accomplished its acquisition of Kerensen Consulting in August 2015.
Under the Plan, Salesforce granted a total of 82,779 restricted stock units (“RSUs”) to 26 employees. These RSUs vest over 4 years with 25 percent of the RSUs vesting on the first anniversary of the grant date and the balance vesting quarterly thereafter in 12 equal installments, subject to continued service through each applicable vesting date. Each of the employees who received an equity award is a non-executive employee and joined as a result of the acquisition.
salesforce.com, inc. is a provider of enterprise cloud computing solutions that comprise apps and platform services, in addition to professional services. The Company focuses on customer relationship administration (CRM).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
